Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eike C Buss

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Journal of Cancer|July 29, 2011
Leukemia stem cellsEike C Buss, Anthony D Ho
Haematologica|February 17, 2005
Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses - follow-up of three patientsStefan Fruehauf, Eike C Buss, Julian Topaly, et al.
Haematologica|June 23, 2006
Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses. A follow-up of three patientsStefan Fruehauf, Eike C Buss, Julian Tropaly, et al.
European Journal of Haematology|February 14, 2004
Secondary follicular lymphoma of the bone, transformed into large cell lymphoma, in a patient with chronic lymphocytic leukaemia: an uncommon manifestation of Richter's syndromeManfred Hensel, Eike C Buss, Markus Tiemann, et al.
Haematologica|December 24, 2002
Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemiaStefan Fruehauf, Julian Topaly, Eike C Buss, et al.
European Journal of Haematology|February 18, 2014
Imatinib-supplemented myeloablative total-body irradiation/cyclophosphamide conditioning prior to allogeneic stem cell transplantation as consolidation treatment in patients with blast crisis of chronic myeloid leukemiaAleksandar Radujkovic, Peter Dreger, Ute Hegenbart, et al.
International Journal of Cancer|June 5, 2014
Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263Gernot Polier, Marco Giaisi, Rebecca Köhler, et al.
Stem Cells (Dayton, Ohio)|July 28, 2004
Clonal analysis of individual marrow-repopulating cells after experimental peripheral blood progenitor cell transplantationK Zsuzsanna Nagy, Stephanie Laufs, Bernhard Gentner, et al.
Journal of Leukocyte Biology|July 26, 2008
A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cellsTanja Nicole Hartmann, Valentin Grabovsky, Ronit Pasvolsky, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 21, 2013
Identification and separation of normal hematopoietic stem cells and leukemia stem cells from patients with acute myeloid leukemiaVan T Hoang, Isabel Hoffmann, Karina Borowski, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|July 29, 2011
Leukemia stem cellsEike C Buss, Anthony D Ho
Haematologica|February 17, 2005
Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses - follow-up of three patientsStefan Fruehauf, Eike C Buss, Julian Topaly, et al.
Haematologica|June 23, 2006
Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses. A follow-up of three patientsStefan Fruehauf, Eike C Buss, Julian Tropaly, et al.
European Journal of Haematology|February 14, 2004
Secondary follicular lymphoma of the bone, transformed into large cell lymphoma, in a patient with chronic lymphocytic leukaemia: an uncommon manifestation of Richter's syndromeManfred Hensel, Eike C Buss, Markus Tiemann, et al.
Haematologica|December 24, 2002
Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemiaStefan Fruehauf, Julian Topaly, Eike C Buss, et al.
European Journal of Haematology|February 18, 2014
Imatinib-supplemented myeloablative total-body irradiation/cyclophosphamide conditioning prior to allogeneic stem cell transplantation as consolidation treatment in patients with blast crisis of chronic myeloid leukemiaAleksandar Radujkovic, Peter Dreger, Ute Hegenbart, et al.
International Journal of Cancer|June 5, 2014
Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263Gernot Polier, Marco Giaisi, Rebecca Köhler, et al.
Stem Cells (Dayton, Ohio)|July 28, 2004
Clonal analysis of individual marrow-repopulating cells after experimental peripheral blood progenitor cell transplantationK Zsuzsanna Nagy, Stephanie Laufs, Bernhard Gentner, et al.
Journal of Leukocyte Biology|July 26, 2008
A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cellsTanja Nicole Hartmann, Valentin Grabovsky, Ronit Pasvolsky, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 21, 2013
Identification and separation of normal hematopoietic stem cells and leukemia stem cells from patients with acute myeloid leukemiaVan T Hoang, Isabel Hoffmann, Karina Borowski, et al.
Pageof 2